Skip to main content
. 2008 Nov 17;113(16):3673–3678. doi: 10.1182/blood-2008-09-177329

Table 1.

Baseline characteristics for all patients enrolled in the study

Characteristic Value
Median age, y 61 (52-75)
Median prior therapies 0 (0-2)
No prior therapy 27 (63%)
Median bone marrow involvement 55% (5%-100%)
Adenopathy and/or splenomegaly 5 (12%)
Median IgM, mg/dL 3840 (655-10500)
IgM > 3000 mg/dL 27 (63%)
Hematocrit < 30% 15 (35%)
Platelets < 100 000/mm3 4 (9%)